Free agency opens with the Mets losing star closer Edwin Díaz, while the Brewers face a quieter offseason and the Royals emerge as a surprise suitor for Bo Bichette.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Reserve Bank Australia holds key rate amid inflation concerns, signaling caution on further easing.
Free agency opens with the Mets losing star closer Edwin Díaz, while the Brewers face a quieter offseason and the Royals emerge as a surprise suitor for Bo Bichette.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Reserve Bank Australia holds key rate amid inflation concerns, signaling caution on further easing.